Skip to main content

Table 1 Baseline characteristics of mothers

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

Characteristics of mothers Telbivudine group
(N = 139)
Control group
(N = 102)
P value
Age, years, median (range) 26 (20–43) 26 (18–42) 0.061
Prior pregnancy, median (range) 1 (1–4) 1 (1–4) 0.224
HBV DNA levels, log10 IU/mL, median (range) 7.73 (6.04~9.30) 7.72 (6.03~9.00) 0.858
HBV DNA levels > 108 IU/mL, n (%) 60 (43.2%) 45 (44.1%) 0.883
HBV DNA levels 107–108 IU/mL, n (%) 62 (44.6%) 36 (35.3%) 0.184
ALT level, U/L, median (range) 117 (56–1166) 164 (53–1025) 0.867
AST level, U/L, median (range) 112 (32–1061) 101 (35–539) 0.301
Elevated AST levels, n (%) 136 (97.8%) 101 (99.0%) 0.640
TBIL, μmol/L, median (range) 11 (4–125) 11 (3–96) 0.911
HBeAg positive, n (%) 126 (90.6%) 91 (89.2%) 0.714